Global Competent Cells Strategic Business Report 2023: Increasing Research on Cloning Demands Competent Cells Requirement

Company Logo
Company Logo

Global Market for Competent Cells

Global Market for Competent Cells
Global Market for Competent Cells

Dublin, Feb. 03, 2023 (GLOBE NEWSWIRE) -- The "Competent Cells - Global Strategic Business Report" report has been added to's offering.

The global market for Competent Cells estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$3.2 Billion by 2030, growing at a CAGR of 8% over the analysis period 2022-2030.

Chemically Competent Cells, one of the segments analyzed in the report, is projected to record 7.3% CAGR and reach US$2.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Electrocompetent Cells segment is readjusted to a revised 9.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $502.7 Million, While China is Forecast to Grow at 7.5% CAGR

The Competent Cells market in the U.S. is estimated at US$502.7 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$553.3 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Select Competitors (Total 46 Featured) -

  • Agilent Technologies, Inc.

  • Bio-Rad Laboratories, Inc.

  • GenScript Biotech Corporation

  • Illumina, Inc.

  • Merck KgaA

  • New England Biolabs, Inc.

  • OriGene Technologies, Inc.

  • Promega Corporation

  • Qiagen NV

  • Takara Bio, Inc.

  • Thermo Fisher Scientific, Inc.

  • Zymo Research Corporation

What`s New for 2023?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

  • Global competitiveness and key competitor percentage market shares

  • Market presence across multiple geographies - Strong/Active/Niche/Trivial

  • Online interactive peer-to-peer collaborative bespoke updates

  • Access to digital archives and Research Platform

  • Complimentary updates for one year

Report Attribute


No. of Pages


Forecast Period

2022 - 2030

Estimated Market Value (USD) in 2022

$1.7 Billion

Forecasted Market Value (USD) by 2030

$3.2 Billion

Compound Annual Growth Rate


Regions Covered


Key Topics Covered:




  • Influencer Market Insights

  • World Market Trajectories

  • Competent Cells - Global Key Competitors Percentage Market Share in 2022 (E)

  • Competent Cells Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

  • Impact of Covid-19 and a Looming Global Recession

  • Clean-Label Starch Innovations

  • Chemically Competent Cells Segment Dominate in North America

  • Drivers & Restrains Summarized for Competent Cells Market

  • Cloning is Expected to Take the Largest Share of Competent Cells Market

  • Competent Cells Growth Outlook

  • Competent Cells Application Trends

  • Academic and Research Institutes Emerge as Largest End Users of Competent Cells Market

  • Leading Players in competent cells market



  • Advancements in Molecular Cloning Drives Competent Cell Market

  • Drivers and Restraints Summarised

  • SGI-DNA Inc has Launched VmaxT Express Chemically Competent Cells .

  • Increasing Research on Cloning Demands Competent Cells Requirement

  • Increasing Intensity of Research and Technological Advancements Drives Market

  • Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022

  • As the Foundation for Modern Biomolecular Research, Importance of Recombinant Proteins Spurs Demand for Competent Cells

  • Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022

  • As Molecular Engineering Takes Huge Strides Forward in Manipulating & Harnessing the DNA for the Production of More Potent Therapies, Poised to Benefit are Ready-to-Use Competent Cells

  • Escherichia coli, the Most Widely Used Organism in the Expression of Cloned Proteins

  • Need for DNA Library Construction in Molecular Cloning Benefits Demand for Competent Cells

  • Need for Faster Characterization Proteins & More Efficient Protein Expression Spurs the Use of Competent Cells

  • Rise of Protein Expression Services Offering Flexible, Low-Cost Production of High-Quality, Bioactive Recombinant Proteins, Bodes Well for Market Growth

  • Higher Transformation Efficiencies Give Electroporation an Edge Over Chemical Methods

  • Heat Shock Treatment for Transformation of Competent Cells, Another Popular Method

  • Increased Investments in Life Sciences Research to Expand the Addressable Market Opportunity for Competent Cells

  • Rising Global Pharmaceutical R&D Offers a Fertile Environment for the Growth in Demand for Competent Cells: Global Pharmaceutical R&D (In US$ Billion) for the Years 2017, 2019, 2022 and 2024

  • Continuous Developments in Chemical Transformation Technologies to Benefit Market Growth

  • Rise in Non-Communicable Diseases, a Key Macro Trend Shaping Demand for Recombinant Enzymes & Proteins in Drug Discovery

  • Mind Bending Economic Burden of Noncommunicable Diseases (NCDs) Drives Urgent Investments in Drug Research & Development, Opening Up Opportunities for Competent Cells in Mass Production of Therapeutic Proteins: Cumulative Global Burden of NCDs (In US$ Trillion) for the Period 2011-2030

  • Cell Free Protein Expression & the Accompanying Promise of the Development of a Versatile Mass Production System for Protein Expression to Benefit Market Growth




For more information about this report visit


CONTACT: CONTACT: Laura Wood,Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900